Activated ras oncogenes in human thyroid cancers
- PMID: 3293774
Activated ras oncogenes in human thyroid cancers
Abstract
Human thyroid epithelial (follicular) cells give rise to two malignant tumors--"follicular" carcinomas, which metastasize almost exclusively via the bloodstream, and "papillary" carcinomas, which metastasize predominantly via lymphatics (Williams, E. D. In: W. Duncan (ed.), Recent Results in Cancer Research: Thyroid Cancer, pp. 47-55. Berlin: Springer-Verlag, 1980). We have investigated whether this contrast in biological behavior might be associated with different patterns of oncogene activation. DNA transfection analysis of five follicular and ten papillary cancers indeed showed a statistically significant difference in the pattern of genes responsible, activated ras oncogenes being found in 80% of follicular tumors but only 20% of papillary tumors. In addition, in follicular cancers we have found activation of all three ras oncogenes (H-ras, K-ras, and N-ras), the first time that this has been demonstrated in a primary human tumor type (as opposed to cell lines). We suggest therefore that ras activation may be an important determinant of metastatic capability in these epithelial cancers.
Similar articles
-
Detection of activated ras oncogenes in human thyroid carcinomas.Oncogene. 1988 Apr;2(4):403-6. Oncogene. 1988. PMID: 3283656
-
ras mutations are associated with aggressive tumor phenotypes and poor prognosis in thyroid cancer.J Clin Oncol. 2003 Sep 1;21(17):3226-35. doi: 10.1200/JCO.2003.10.130. J Clin Oncol. 2003. PMID: 12947056
-
Thyroid targeting of the N-ras(Gln61Lys) oncogene in transgenic mice results in follicular tumors that progress to poorly differentiated carcinomas.Oncogene. 2006 Aug 31;25(39):5467-74. doi: 10.1038/sj.onc.1209527. Epub 2006 Jun 19. Oncogene. 2006. PMID: 16785999
-
Genetic mutations in thyroid carcinoma.Minerva Endocrinol. 2009 Mar;34(1):11-28. Minerva Endocrinol. 2009. PMID: 19209125 Review.
-
[Activated oncogenes in human tumors].Bull Cancer. 1987;74(6):607-21. Bull Cancer. 1987. PMID: 3325106 Review. French.
Cited by
-
Prevalence of K-RAS Codons 12 and 13 Mutations in Locally Advanced Head and Neck Squamous Cell Carcinoma and Impact on Clinical Outcomes.Int J Otolaryngol. 2013;2013:848021. doi: 10.1155/2013/848021. Epub 2013 Apr 30. Int J Otolaryngol. 2013. PMID: 23737793 Free PMC article.
-
Analysis of RAS mutation in thyroid nodular hyperplasia and follicular neoplasm in a Korean population.Endocrinol Diabetes Metab. 2018 Sep 3;1(4):e00040. doi: 10.1002/edm2.40. eCollection 2018 Oct. Endocrinol Diabetes Metab. 2018. PMID: 30815568 Free PMC article.
-
Intravenous administration of Reolysin, a live replication competent RNA virus is safe in patients with advanced solid tumors.Invest New Drugs. 2010 Oct;28(5):641-9. doi: 10.1007/s10637-009-9279-8. Epub 2009 Jul 2. Invest New Drugs. 2010. PMID: 19572105 Free PMC article. Clinical Trial.
-
Radioiodine-associated thyroid cancers.World J Surg. 1994 Jul-Aug;18(4):522-8. doi: 10.1007/BF00353754. World J Surg. 1994. PMID: 7725739
-
Identification of Long Noncoding RNAs Deregulated in Papillary Thyroid Cancer and Correlated with BRAFV600E Mutation by Bioinformatics Integrative Analysis.Sci Rep. 2017 May 10;7(1):1662. doi: 10.1038/s41598-017-01957-0. Sci Rep. 2017. PMID: 28490781 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Medical
Research Materials
Miscellaneous